TP53 and glioma: Besides immune signaling pathways, many cancer-associated pathways were highly enriched in immunity-high gliomas, such as MAPK signaling, cell cycle, p53 signaling, VEGF signaling, glycolysis, and PPAR signaling (Fig. 5a).